Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Avoid Large Crowds In Bali & Swim At This Peaceful Waterfall With A Gorgeous, Natural Pool- Book excerpt: "Enough" by Dr. Ania Jastreboff and Oprah Winfrey
- Nordic people know how to beat the winter blues. Here's how to find light in the darkest months
- Viable Correspondence: Building Solid Connections
- Step by step instructions to Keep up with Great Hand Cleanliness Before Handshakes
- He made a name for himself posting thirst traps on TikTok. Now he's the star of a wildly popular rom-com.
- Watch interstellar comet 3I/ATLAS make its closest approach to Earth in free livestream on Dec. 18
- Can ICE agents detain U.S. citizens? What powers do they have to arrest people? Your most common questions answered.
- The most effective method to Boost Benefits in Gold Speculation: Master Techniques and Tips
